Response to Rivastigmine Transdermal Patch or Memantine plus Rivastigmine Patch is affected by Apolipoprotein E Genotype in Alzheimer PatientsHyun Jeong Han, Seong Hye Choi, Hae Ri Na et al.|Dementia and Geriatric Cognitive Disorders|2012Cited by 21
Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer’s dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trialKyung Won Park, Seong Hye Choi, Eun Joo Kim et al.|PLoS ONE|2017Cited by 11